Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Antibiotics versus no antibiotics for flexible ureteroscopy with a negative-pressure suction sheath

Official title: An International Multicenter Study on the Antimicrobial Prophylaxis Strategy for Flexible Ureteroscopic Lithotripsy Combined With a Flexible Negative Pressure Suction Sheath

Run by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · NCT07246967 · Data updated 2026-11-12

This trial will test whether adults at low risk of infection having single-use flexible ureteroscopy with a negative-pressure suction sheath can safely skip the usual single-dose antibiotic before surgery.

More Urolithiasis trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment500 (estimated)
SponsorShanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedMarch 2027
Study endsDecember 2027
Registry record updatedApril 23, 2026
Trial IDNCT07246967 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–75 with renal or upper ureteral stones ≤2 cm who are scheduled for single-use flexible ureteroscopic lithotripsy with a negative-pressure suction sheath, have no preoperative infection symptoms and a negative preoperative urine culture, and are not immunosuppressed are the intended participants.

Probably not a fit

Patients with active infection or positive urine culture, immunosuppression, urinary tract obstruction from anatomic causes, pregnancy or lactation, recent antibiotic use, or other exclusion criteria are unlikely to benefit from the no-antibiotic approach and are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an international, multicenter, prospective, randomized, controlled non-inferiority trial comparing no antimicrobial prophylaxis to a single-dose prophylactic antibiotic in low-infection-risk patients undergoing single-use flexible ureteroscopic lithotripsy with a flexible negative-pressure suction sheath. Eligible participants are randomized 1:1 with stratification by center and stone size (≤1.5 cm versus >1.5 cm and ≤2 cm). Surgeries are performed by surgeons experienced with the negative-pressure sheath and recorded using a standardized surgical form. The trial compares post-operative infection-related outcomes between the two groups to determine if withholding prophylaxis is not worse than standard single-dose prophylaxis.

Why it matters

Potential benefit: If successful, the approach could safely reduce unnecessary antibiotic use, lowering side effects and antibiotic resistance while maintaining low post-operative infection rates.

How similar studies have gone: Previous trials have suggested withholding prophylaxis can be safe in selected low-risk ureteroscopy cases, but using a flexible negative-pressure suction sheath in this randomized international non-inferiority setting is relatively novel and large definitive evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-75 years.
2. Diagnosed by CT with renal and/or upper ureteral stones, with the longest stone diameter being ≤2cm.
3. Scheduled to undergo fURS lithotripsy.
4. No preoperative symptoms of infection such as chills and fever, and the most recent preoperative urine culture is negative.
5. No immunosuppressive status and no urinary flow obstruction caused by anatomical abnormalities.
6. No use of long-acting antimicrobial agents within 7 days prior to surgery, and no use of intermediate or short-acting antimicrobial agents within 72 hours prior to surgery.
7. Has signed and dated an informed consent form, indicating that the patient or their legal representative has been fully informed about the study-related information and has agreed to participate.

Exclusion Criteria:

1. Pregnant or lactating women.
2. Allergy to the investigational drug(s).
3. Participation in other clinical trials within 30 days.
4. Presence of other active infection foci requiring antimicrobial treatment.
5. Concomitant severe systemic diseases, such as cardiac or pulmonary disease, malignant tumors, and immunodeficiency states.
6. Congenital malformations of the urinary tract.
7. History of kidney transplantation or urinary diversion surgery.
8. Unable to provide samples or complete follow-up according to the study protocol.
9. Unable to provide informed consent.
10. Inability to achieve complete placement of the flexible negative-pressure suction sheath.
11. Any other conditions that the investigator deems unsuitable for participation in this study.
12. History of diabetes mellitus, immunocompromised.
13. Renal insufficiency, neurogenic bladder.
14. Recent preoperative history of stone-related fever.
15. Long-term indwelling urinary drainage tube.
16. Urine white blood cells \>5/HPF (High Power Field) or positive for urine nitrites.
17. Large stone burden (e.g., staghorn calculus) or moderate to severe hydronephrosis.
18. Imaging findings showing turbid urine in the renal pelvis where pyonephrosis or infectious stones cannot be excluded.

Where it's running

  • Shanghai General Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Yi Shao — Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
  • Study coordinator: Ziyang Zheng
  • Email: zhengzzy0116@163.com
  • Phone: 18861968196

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.